A. Składanowski

发表

Synthesis and steroid sulfatase inhibitory activities of N-alkanoyl tyramine phosphates and thiophosphates†

A. Wołoś, Mateusz Daśko, J. Rachon, 2015 .

Structural Determinants of Imidazoacridinones Facilitating Antitumor Activity Are Crucial for Substrate Recognition by ABCG2

Yehuda G Assaraf, Y. Assaraf, A. Składanowski, 2009, Molecular Pharmacology.

Synthesis and biological evaluation of novel analogues of batracylin with synthetic amino acids and adenosine: an unexpected effect on centromere segregation in tumor cells through a dual inhibition of topoisomerase IIα and Aurora B

A. Składanowski, G. Cholewiński, Marcin Serocki, 2016 .

Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more.

A. Składanowski, M. Sabisz, 2008, Current pharmaceutical biotechnology.

Alteration of the daunorubicin‐triggered sphingomyelin‐ceramide pathway and apoptosis in MDR cells: Influence of drug transport abnormalities

G. Laurent, A. Larsen, A. Składanowski, 1999, International journal of cancer.

Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: Implications for drug resistance and in vitro drug screening models

A. Składanowski, M. Sabisz, 2009, Cell cycle.

Solid phase synthesis and biological activity of tuftsin conjugates.

A. Składanowski, Marcin Serocki, K. Dzierzbicka, 2011, Journal of medicinal chemistry.

Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation.

A. Składanowski, G. Cholewiński, Marcin Serocki, 2015, European journal of medicinal chemistry.

Influence of S‐Oxidation on Cytotoxic Activity of Oxathiole‐Fused Chalcones

A. Składanowski, M. Wojciechowski, M. Sabisz, 2016, Chemical biology & drug design.

Structural Factors Affecting Cytotoxic Activity of (E)‐1‐(Benzo[d ][1,3]oxathiol‐6‐yl)‐3‐phenylprop‐2‐en‐1‐one Derivatives

J. Wietrzyk, A. Składanowski, M. Sabisz, 2014, Chemical biology & drug design.

Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line.

E. AUGUSTYNOWICZ-KOPEĆ, A. Składanowski, M. Sabisz, 2007, Chemical & pharmaceutical bulletin.

Cancer Stem Cells in Drug Resistance and Drug Screening: Can We Exploit the Cancer Stem Cell Paradigm in Search for New Antitumor Agents?

A. Składanowski, M. Sabisz, 2011 .

Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.

Mateusz Daśko, J. Rachon, K. Kubiński, 2017, European journal of medicinal chemistry.

Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.

E. AUGUSTYNOWICZ-KOPEĆ, A. Składanowski, M. Sabisz, 2007, European journal of medicinal chemistry.

Dual Inhibition of PI3K/Akt Signaling and the DNA Damage Checkpoint in p53-Deficient Cells with Strong Survival Signaling: Implications for Cancer Therapy

A. Larsen, A. Składanowski, Annette K Larsen, 2007, Cell cycle.

Novel approaches in the synthesis of batracylin and its analogs: rebirth of an old player?

A. Składanowski, K. Dzierzbicka, W. Januchta, 2012, Current medicinal chemistry.

Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling

A. Escargueil, L. Meijer, L. Meijer, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin.

A. Składanowski, M. Wojciechowski, M. Sabisz, 2015, European journal of medicinal chemistry.

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

A. Escargueil, A. Larsen, A. Składanowski, 2000, Pharmacology & therapeutics.

The roles of DNA topoisomerase II during the cell cycle.

A. Larsen, A. Składanowski, K. Bojanowski, 1996, Progress in cell cycle research.

Downregulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M and increased survival to microtubule-interacting agents

A. Escargueil, A. Larsen, A. Składanowski, 2005 .

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

Y. Assaraf, H. Bergh, T. Sarna, 2012, Cell Death and Disease.

Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death.

A. Larsen, A. Składanowski, A. Składanowski, 1998, Biochimica et biophysica acta.

DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.

A. Składanowski, M. Sabisz, P. Bozko, 2009, Chemical reviews.

Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL-60 cells

G. Laurent, A. Larsen, A. Składanowski, 1999, British Journal of Cancer.